NR3C2 and myeloid sarcoma: We have focused on the expression and function of MCR in oligodendroglia (OL), the myelin producing cells of the central nervous system (CNS), with the goal of identifying new therapeutic approaches to decrease CNS damage in multiple sclerosis (MS) as well as to promote repair.